1. Physicochemical characterizations of safranal-β-cyclodextrin inclusion complexes prepared by supercritical carbon dioxide and conventional methods;Abbaszadegan;J. Incl. Phenom. Macrocycl. Chem.,2015
2. Inhibitory effect of prostaglandin-E1 on laurate-induced peripheral vascular occlusive sequelae in rabbits—optimized topical formulations ith beta-cyclodextrin derivative and penetration enhancer HPE-101;Adachi;J. Pharm. Pharmacol.,1992
3. Cyclodextrins—a review on pharmaceutical application for drug delivery;Agrawal;Int. J. Pharm. Front. Res.,2012
4. Inclusion complexes of sunscreen agents with β-cyclodextrin: spectroscopic and molecular modeling studies;Al-Rawashdeh;J. Spectrosc.,2013
5. Ameri, M., Cormier, M., Maa, Y.-F., Daddona, P., Gale, R.M., 2005. Apparatus and method for transdermal delivery of fentanyl-based agents. Patent WO2005102334 A2.